There are several stocks trading more heavily than usual this morning, and also experiencing large gains or drops in share prices. These include LiveDeal Inc. (NASDAQ: LIVE), Cell Therapeutics Inc. (NASDAQ: CTIC), American DG Energy Inc. (NASDAQ: ADGE), China Sky One Medical Inc. (NASDAQ: CSKI), and Bacterin International Holdings Inc. (NASDAQ: BONE).
After the 45 minutes of trading this morning, LiveDeal is up nearly 23% at $3.76. Volume is already nearly equal to the daily average. The customer acquisition company regained its compliance with Nasdaq listing requirements.
American DG Energy is up about 4% at $1.60. Volume is already higher than the daily average. The energy systems maker has signed a 15-year energy supply agreement with a 225-unit high-rise in New Jersey.
China Sky One Medical is down nearly -19% at $0.92, after posting a new 52-week low of $0.89 earlier. Volume is already more than double the daily average. The nutritional supplement maker’s CFO resigned, following the CEO’s decision last week to take a medical leave.
Bacterin is up about 4% at $2.60. Volume has nearly reached the daily average. The medical device maker’s stock is down -46% for the year and today’s increase likely indicates some value hunting on the part of investors.
Paul Ausick
Essential Tips for Investing (Sponsored)
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
